The blockade of immune checkpoints in cancer immunotherapy

Pardoll, Drew M.·2012·Nature Reviews Cancer

DOI 10.1038/nrc3239

Cited by (1,121)

Items 901–1,000 of 1,121

Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma
Roger B. Cohen, Jean‐Pierre Delord, Toshihiko Doi, Sarina Anne Piha-Paul, Stephen V. Liu, Jill Gilbert, Alain Patrick Algazi, Silvia Damian, Ruey‐Long Hong, Christophe Le Tourneau et al. · 2018 · American Journal of Clinical Oncology
Clinical and Pathological Aspects of Silent Pituitary Adenomas
Juliana Drummond, Federico Roncaroli, Ashley Barry Grossman, Márta Korbonits · 2018 · The Journal of Clinical Endocrinology & Metabolism
Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
Xingliang Guo, Hua Jiang, Bizhi Shi, Min Zhou, Honghong Zhang, Zhimin Shi, Guoxiu Du, Hong Luo, Xiuqi Wu, Yi Wang et al. · 2018 · Frontiers in Pharmacology
Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity
Yongkui Li, Min Fang, Jian Zhang, Jian Wang, Yu Song, Jie Shi, Wei Li, Gang Wu, Jinghua Ren, Zheng Wang et al. · 2015 · OncoImmunology
The First-week Proliferative Response of Peripheral Blood PD-1+CD8+ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors
Kyung Hwan Kim, Jinhyun Cho, Bo Mi Ku, Jiae Koh, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Jaekyung Cheon, Young Joo Min, Su‐Hyung Park et al. · 2019 · Clinical Cancer Research
Dissection of intercellular communication using the transcriptome-based framework ICELLNET
Floriane Noël, Lucile Massenet-Regad, Irit Carmi-Levy, Antonio Cappuccio, Maximilien Grandclaudon, Coline Trichot, Yann Kieffer, Fatima Mechta‐Grigoriou, Vassili Soumelis · 2021 · Nature Communications
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
Remy Thomas, Ghaneya Al‐Khadairi, Julie V. Decock · 2021 · Frontiers in Oncology
Recent Advances in Engineered Materials for Immunotherapy‐Involved Combination Cancer Therapy
Jun‐Long Liang, Guo‐Feng Luo, Wei‐Hai Chen, Xian‐Zheng Zhang · 2021 · Advanced Materials
RETRACTED: Nanoscale Metal-Organic Framework Mediates Radical Therapy to Enhance Cancer Immunotherapy
Kaiyuan Ni, Theint Aung, Shuyi Li, Nina Fatuzzo, Xing‐Jie Liang, Wenbin Lin · 2019 · Chem · Retracted
A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy
Lupeng Ye, Jonathan Joon-Young Park, Lei Peng, Quanjun Yang, Ryan Dz-Wei Chow, Matthew B. Dong, Stanley Z. Lam, Jianjian Guo, Erting Tang, Yueqi Zhang et al. · 2022 · Cell Metabolism
Role of PD‐L1 Expression in Non‐Small Cell Lung Cancer and Their Prognostic Significance according to Clinicopathological Factors and Diagnostic Markers
Pawelczyk, Konrad, Piotrowska, Aleksandra, Ciesielska, Urszula, Jablonska, Karolina, Glatzel-Plucinska, Natalia, Grzegrzolka, Jedrzej, Podhorska-Okolow, Marzenna, Dziegiel, Piotr, Nowinska, Katarzyna · 2019 · International Journal of Molecular Sciences
Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
Gao, Jing, Wang, Wei-qi, Pei, Qing, Lord, Megan S., Yu, Hai-jun · 2020 · Acta Pharmacologica Sinica
Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma
Xian-De Liu, Anh G. Hoang, Lijun Zhou, Sarathi Kalra, Alper Yetil, Mianen Sun, Zhiyong Ding, Xuesong Zhang, Shanshan Bai, Péter Germán et al. · 2015 · Cancer Immunology Research
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
Rossana Franzin, Giuseppe Stefano Netti, Federica Spadaccino, Camillo Porta, Loreto Gesualdo, Giovanni Stallone, Giuseppe Castellano, Elena Ranieri · 2020 · Frontiers in Immunology
Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment
Wen Li, Feifei Li, Xia Zhang, Hui‐Kuan Lin, Chuan Shan Xu · 2021 · Signal Transduction and Targeted Therapy
Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
Abhisek Swaika, William A. Hammond, Richard Wayne Joseph · 2015 · Molecular Immunology
Parallels between Cancer and Infectious Disease
Richard S. Hotchkiss, Lyle L. Moldawer · 2014 · New England Journal of Medicine
Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1
Sabrina Jutz, Judith Maria Leitner, Klaus G. Schmetterer, Iago Doel-Perez, Otto Majdic, Katharina Grabmeier‐Pfistershammer, Wolfgang Paster, Johannes B. Huppa, Peter Steinberger · 2016 · Journal of Immunological Methods
Early Use of Systemic Corticosteroids in Patients with Advanced NSCLC Treated with Nivolumab
Susan Combs Scott, Nathan A. Pennell · 2018 · Journal of Thoracic Oncology
LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis
Bauché, David, Joyce-Shaikh, Barbara, Jain, Renu, Grein, Jeff, Ku, Karin S., Blumenschein, Wendy M., Ganal-Vonarburg, Stephanie C., Wilson, Douglas C., McClanahan, Terrill K., Malefyt, Rene de Waal et al. · 2018 · Immunity
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
Jiawen Cui, Yao Li, Yang Yang, Hai‐Kui Yang, Jia-Mei Dong, Zhi-Hua Xiao, Xin He, Jiahao Guo, Ruiqi L. Wang, Bo Dai et al. · 2024 · Biomedicine & Pharmacotherapy
Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer
Débora De Melo Gagliato, Denis L. Fontes Jardim, Mario Marchesi, Gabriel N. Hortobágyi · 2016 · Oncotarget
Neurological toxicities associated with immune-checkpoint inhibitors
Mehdi Touat, Daniel Talmasov, Damien Ricard, Dimitri Psimaras · 2017 · Current Opinion in Neurology
The new era of nanotechnology, an alternative to change cancer treatment
Ancuta Maria Jurj, Cornelia Braicu, Laura Pop, Ciprian Tomuleasa, Claudia Diana Gherman, Ioana Berindan‐Neagoe · 2017 · Drug Design Development and Therapy
The multifaceted role of autophagy in cancer and the microenvironment
Hendrik Folkerts, Susan Hilgendorf, Edo Vellenga, Edwin Bremer, Valerie R. Wiersma · 2018 · Medicinal Research Reviews
In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras -Mutant Lung Adenocarcinoma
Fei Li, Qingyuan Huang, Troy A. Luster, Hai Hu, Hua Zhang, Wai‐Lung Ng, Alireza Khodadadi‐Jamayran, Wei Wang, Ting Chen, Jiehui Deng et al. · 2019 · Cancer Discovery
Immunotherapy for glioblastoma: the promise of combination strategies
Mathilde Bausart, Véronique Préat A, Alessio Malfanti · 2022 · Journal of Experimental & Clinical Cancer Research
Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases
Alice Tison, Soizic Garaud, Laurent Chiche, Divi Cornec, Marie Kostine · 2022 · Nature Reviews Rheumatology
Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development
Lin Tang, Sheng Dong Pan, Xuyong Wei, Xiao Xu, Qiang Wei · 2023 · Molecular Therapy
Nivolumab: Targeting PD-1 to Bolster Antitumor Immunity
Julie Renee Brahmer, Hans J. Hammers, Evan J. Lipson · 2015 · Future Oncology
Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
Hae Il Jung, Dongjun Jeong, Sanghee Ji, Tae Sung Ahn, Sang Ho Bae, Susie Chin, Jun Chul Chung, Hyung Chul Kım, Moon Soo Lee, Moo Jun Baek · 2016 · Cancer Research and Treatment
Immunoregulatory functions of VISTA
Elizabeth C. Nowak, Janet Louise Lines, Frederick S. Varn, Jie Deng, Aurélien Sarde, Rodwell Mabaera, Anna Kuta, Isabelle Le Mercier, Chao Cheng, Randolph J. Noelle · 2017 · Immunological Reviews
STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC
Lin‐Lin Bu, Guang‐Tao Yu, Lei Wu, L. Mao, Wei‐Wei Deng, Jinmin Liu, Ashok B. Kulkarni, W.F. Zhang, Longjianjie Zhang, Zhi‐Jun Sun · 2017 · Journal of Dental Research
Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses
Xi Chen, Xiaohui Pan, Wenxin Zhang, Hongjie Guo, Shuyuan Cheng, Qiaojun He, Bo Yang, Ling Ding · 2019 · Acta Pharmaceutica Sinica B
Supramolecular Assembled Programmable Nanomedicine As In Situ Cancer Vaccine for Cancer Immunotherapy
Yu Zhang, Sheng Ma, Xinming Liu, Yudi Xu, Jiayu Zhao, Xinghui Si, Hongxiang Li, Zichao Huang, Zhenxin Wang, Zhaohui Tang et al. · 2021 · Advanced Materials
Cancer Vaccines, Adjuvants, and Delivery Systems
Paston, Samantha J., Brentville, Victoria A., Symonds, Peter, Durrant, Lindy G. · 2021 · Frontiers in Immunology
<scp>UV</scp>‐induced somatic mutations elicit a functional T cell response in the <scp>YUMMER</scp>1.7 mouse melanoma model
Wang, Jake, Perry, Curtis J., Meeth, Katrina, Thakral, Durga, Damsky, William, Micevic, Goran, Kaech, Susan, Blenman, Kim, Bosenberg, Marcus · 2017 · Pigment Cell & Melanoma Research
Hypoxia-inducible factors: a central link between inflammation and cancer
Triner, Daniel, Shah, Yatrik M. · 2016 · Journal of Clinical Investigation
Combining Targeted Therapy With Immunotherapy in BRAF-Mutant Melanoma: Promise and Challenges
Siwen Hu‐Lieskovan, Lídia Robert, Blanca Homet Moreno, Antoni Ribas · 2014 · Journal of Clinical Oncology
Nanoscaled red blood cells facilitate breast cancer treatment by combining photothermal/photodynamic therapy and chemotherapy
Guoyun Wan, Bowei Chen, Ling Li, Dan Wang, Shurui Shi, Tao Zhang, Yue Wang, Lianyun Zhang, Yinsong Wang · 2017 · Biomaterials
Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy
Shan Gao, Dongjuan Yang, Yan Fang, Xiaojie Lin, Xuechao Jin, Qi Wang, Xiyan Wang, Liyuan Ke, Kai Shi · 2018 · Theranostics
In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma
Lupeng Ye, Jonathan Joon-Young Park, Matthew B. Dong, Quanjun Yang, Ryan Dz-Wei Chow, Lei Peng, Yaying Du, Jianjian Guo, Xiaoyun Dai, Guangchuan Wang et al. · 2019 · Nature Biotechnology
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation
Vendetti, Frank P., Karukonda, Pooja, Clump, David A., Teo, Troy, Lalonde, Ronald, Nugent, Katriana, Ballew, Matthew, Kiesel, Brian F., Beumer, Jan H., Sarkar, Saumendra N. et al. · 2018 · Journal of Clinical Investigation
Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis
Jiandong Mei, Zhilan Xiao, Chenglin Guo, Qiang Pu, Lin Ma, Chengwu Liu, Feng Lin, Hu Liao, Zongbing You, Lunxu Liu · 2016 · Oncotarget
Role of PD-1 in Immunity and Diseases
Kenji Chamoto, Muna Al-Habsi, Tasuku Honjo · 2017 · Current topics in microbiology and immunology
Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences
Nikko Brix, Anna Tiefenthaller, Heike Anders, Claus Belka, Kirsten Lauber · 2017 · Immunological Reviews
PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma
Afag Asgarova, Kamal Asgarov, Yann Godet, Paul Peixoto, Arulraj Nadaradjane, Michaël Boyer‐Guittaut, Jeanne Galaine, David Guenat, Virginie Mougey, Jérôme Perrard et al. · 2018 · OncoImmunology
Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
Benoı̂t L. Salomon, Mathieu Leclerc, Jimena Tosello, Émilie Ronin, Eliane Piaggio, José Laurent Cohen · 2018 · Frontiers in Immunology
A Dual Immunotherapy Nanoparticle Improves T‐Cell Activation and Cancer Immunotherapy
Yu Mi, Christof C. Smith, Feifei Yang, Yanfei Qi, Kyle C. Roche, Jonathan Stuart Serody, Benjamin Garrett Vincent, Andrew Zhuang Wang · 2018 · Advanced Materials
Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy
Pingsheng Huang, Xiaoli Wang, Xiaoyu Liang, Jing Yang, Chuangnian Zhang, Deling Kong, Weiwei Wang · 2018 · Acta Biomaterialia
Metabolism in tumor microenvironment: Implications for cancer immunotherapy
Rongchen Shi, Yi‐Quan Tang, Hongming Miao · 2020 · MedComm
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead
Kedar Kirtane, Hany Elmariah, Christine H. Chung, Daniel Abate‐Daga · 2021 · Journal for ImmunoTherapy of Cancer
Targeting CAFs to overcome anticancer therapeutic resistance
Phei Er Saw, Jianing Chen, Erwei Song · 2022 · Trends in cancer
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Zaoqu Liu, Zhaokai Zhou, Qin Dang, Hui Min Xu, Jinxiang Lv, Huanyun Li, Xinwei Han · 2022 · Theranostics
Acquired and intrinsic resistance in cancer immunotherapy
Kelderman, Sander, Schumacher, Ton N.M., Haanen, John B.A.G. · 2014 · Molecular Oncology
Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma
Lee, Lik Hang, Cavalcanti, Marcela S, Segal, Neil H, Hechtman, Jaclyn F, Weiser, Martin R, Smith, J Joshua, Garcia-Aguilar, Julio, Sadot, Eran, Ntiamoah, Peter, Markowitz, Arnold J et al. · 2016 · Modern Pathology
The Roles of CD73 in Cancer
Zhaowei Gao, Ke Dong, Huizhong Zhang · 2014 · BioMed Research International
Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
Brandon Kwong, S. Annie Gai, Jamal A. Elkhader, Karl Dane Wittrup, Darrell J. Irvine · 2013 · Cancer Research
Engineering Dendritic-Cell-Based Vaccines and PD-1 Blockade in Self-Assembled Peptide Nanofibrous Hydrogel to Amplify Antitumor T-Cell Immunity
Pengxiang Yang, Huijuan Song, Yibo Qin, Pingsheng Huang, Chuangnian Zhang, Deling Kong, Weiwei Wang · 2018 · Nano Letters
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
Sanjeevani Arora, Rodion A. Velichinskii, Randy W. Lesh, Usman Ali, Michal Jakub Kubiak, Pranshu Bansal, Hossein Borghaei, Martin Joseph Edelman, Yanis Boumber · 2019 · Advances in Therapy
Impact of the immune system and immunotherapy in colorectal cancer.
Janet L. Markman, Stephen Lawrence Shiao · 2015 · PubMed Central
Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination
Hong Jiang, Yisel A. Rivera-Molina, Candelaria Gomez‐Manzano, Karen Clise-Dwyer, Laura C. Bover, Luis M. Vence, Ying Yuan, Frederick F. Lang, Carlo Toniatti, Mohammad Belayat Hossain et al. · 2017 · Cancer Research
Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response
Eric Ubil, Laura S. Caskey, Alisha Holtzhausen, Debra M. Hunter, Charlotte McIlwaine Story, Henry Shelton Earp · 2018 · Journal of Clinical Investigation
The Immune Subtypes and Landscape of Squamous Cell Carcinoma
Bailiang Li, Yi Cui, Dhanya K. Nambiar, John B. Sunwoo, Ruijiang Li · 2019 · Clinical Cancer Research
A comprehensive review of immune checkpoint inhibitors for cancer treatment
Md Aslam Hossain · 2024 · International Immunopharmacology
M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine
Knudson, Karin M., Hicks, Kristin C., Luo, Xiaoling, Chen, Jin-Qiu, Schlom, Jeffrey, Gameiro, Sofia R. · 2018 · OncoImmunology
Programmed Cell Death Ligand 1 Expression in Osteosarcoma
Jacson K. Shen, Gregory Michael Cote, Edwin Choy, Pei Yang, David C. Harmon, Joseph Hasbrouck Schwab, G. Petur Nielsen, Ivan A. Chebib, Soldano Ferrone, Xinhui Wang et al. · 2014 · Cancer Immunology Research
Targeted therapies for treatment of non‐small cell lung cancer—Recent advances and future perspectives
Joan Minguet, Katherine Helen Smith, Peter Bramlage · 2015 · International Journal of Cancer
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Erhao Zhang, Hanmei Xu · 2017 · Journal of Hematology & Oncology
Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications
Grant M. Fischer, Y.N. Vashisht Gopal, Jennifer Leigh McQuade, Weiyi Peng, Ralph J. DeBerardinis, Michael A. Davies · 2017 · Pigment Cell & Melanoma Research
The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy
Diana Klein · 2018 · Frontiers in Oncology
Immune Resistance in Lung Adenocarcinoma
Μάγδα Σπέλλα, Georgios T. Stathopoulos · 2021 · Cancers
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
Sneha Berry, Nicolás A. Giraldo, Benjamin Green, Tricia R. Cottrell, Julie E. Stein, Elizabeth L. Engle, Haiying Xu, Aleksandra Ogurtsova, Charles A. Roberts, Daphne Wang et al. · 2021 · Science
CAR-NK cells for cancer immunotherapy: from bench to bedside
Leisheng Zhang, Meng Yuan, Xiaoming Feng, Zhongchao Han · 2022 · Biomarker Research
The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment
Hendry, Shona A., Farnsworth, Rae H., Solomon, Benjamin, Achen, Marc G., Stacker, Steven A., Fox, Stephen B. · 2016 · Frontiers in Immunology
Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
Michele Ardolino, Camillia S. Azimi, Alexandre Iannello, Troy N. Trevino, Lucas H. Horan, Lily Zhang, Weiwen Deng, Aaron M. Ring, Suzanne Fischer, K. Christopher García et al. · 2014 · Journal of Clinical Investigation
High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers
Michael Hettich, Friederike Braun, Mark Daniel Bartholomä, Reinhold Schirmbeck, Gabriele Niedermann · 2016 · Theranostics
Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α
Yana George Najjar, Patricia A. Rayman, Xuefei Jia, Paul G. Pavicic, Brian I. Rini, Charles S. Tannenbaum, Jennifer S. Ko, Samuel Haywood, Peter A. Cohen, Thomas A. Hamilton et al. · 2016 · Clinical Cancer Research
Tumor-derived exosomes induce CD8+ T cell suppressors
Brian T. Maybruck, Lukas W. Pfannenstiel, Marcela Díaz-Montero, Brian Gastman · 2017 · Journal for ImmunoTherapy of Cancer
Synthesis and Biologic Evaluation of a Novel 18 F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression
David J. Donnelly, R. Adam Smith, Paul E. Morin, Daša Lipovšek, Jochem Gokemeijer, Daniel Cohen, Virginie Lafont, Tritin Tran, Erin L. Cole, Martin C. Wright et al. · 2017 · Journal of Nuclear Medicine
Tumor Abnormality-Oriented Nanomedicine Design
Quan Zhou, Jiajia Xiang, Nasha Qiu, Yechun Wang, Ying Piao, Shiqun Shao, Jianbin Tang, Zhuxian Zhou, Youqing Shen · 2023 · Chemical Reviews
Collateral damage: Insights into bacterial mechanisms that predispose host cells to cancer
Gagnaire, Aurélie, Nadel, Bertrand, Raoult, Didier, Neefjes, Jacques, Gorvel, Jean-Pierre · 2017 · Nature Reviews Microbiology
Programmed cell death‐1 (PD‐1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell–intrinsic PD‐1
Hui Li, Xiaoqiang Li, Shuang Liu, Lei Guo, Bo Zhang, Jubo Zhang, Qing‐Hai Ye · 2017 · Hepatology
The Role of the Estrogen Pathway in the Tumor Microenvironment
Natalie J. Rothenberger, Ashwin Somasundaram, Laura P. Stabile · 2018 · International Journal of Molecular Sciences
Size/Charge Changeable Acidity‐Responsive Micelleplex for Photodynamic‐Improved PD‐L1 Immunotherapy with Enhanced Tumor Penetration
Liangliang Dai, Ke Li, Menghuan Li, Xiaojing Zhao, Zhong Yuan Luo, Lu Lu, Yanfeng Luo, Kaiyong Cai · 2018 · Advanced Functional Materials
Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing
Zhoufeng Wang, Zhe Li, Kun Zhou, Chengdi Wang, Lili Jiang, Li Zhang, Ying Yang, Wenxin Luo, Wenliang Qiao, Gang Wang et al. · 2021 · Nature Communications
Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models
Marcel André Schneider, Laura Heeb, Michał Beffinger, Stanislav Pantelyushin, Michael Linecker, Lilian Roth, Kuno Lehmann, U. Ungethüm, Sebastian Kobold, Rolf Graf et al. · 2021 · Science Translational Medicine
PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
Paiva, B, Azpilikueta, A, Puig, N, Ocio, E M, Sharma, R, Oyajobi, B O, Labiano, S, San-Segundo, L, Rodriguez, A, Aires-Mejia, I et al. · 2015 · Leukemia
Exomics and immunogenics
Stéphane Champiat, Charles Ferté, Sophie Lebel‐Binay, Alexander M.M. Eggermont, Jean‐Charles Soria · 2014 · OncoImmunology
Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer
Dongqiang Zeng, Yunfang Yu, Qiyun Ou, Xiaoyin Li, Ru-Zhi Zhong, Chuanmiao Xie, Qiugen Hu · 2016 · Oncotarget
From monoclonal antibodies to small molecules: the development of inhibitors targeting the PD-1/PD-L1 pathway
Meimiao Zhan, Xueqin Hu, Xiu-Xiu Liu, Ban‐Feng Ruan, Jun Xu, Chenzhong Liao · 2016 · Drug Discovery Today
Inhibiting Metastasis and Preventing Tumor Relapse by Triggering Host Immunity with Tumor-Targeted Photodynamic Therapy Using Photosensitizer-Loaded Functional Nanographenes
Xinhe Yu, Duo Gao, Liquan Gao, Jianhao Lai, Chenran Zhang, Yang Zhao, Lijun Zhong, Bing Jia, Fan Wang, Xiaoyuan Shawn Chen et al. · 2017 · ACS Nano
Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors
de Moel, Emma C., Rozeman, Elisa A., Kapiteijn, Ellen H., Verdegaal, Els M.E., Grummels, Annette, Bakker, Jaap A., Huizinga, Tom W.J., Haanen, John B., Toes, René E.M., van der Woude, Diane · 2019 · Cancer Immunology Research
Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma
Limeta, Angelo, Ji, Boyang, Levin, Max, Gatto, Francesco, Nielsen, Jens · 2020 · JCI Insight
Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma
Zheng Wang, Chuanbao Zhang, Xing Liu, Zhiliang Wang, Lihua Sun, Guanzhang Li, Jingshan Liang, Huimin Hu, Yanwei Liu, Wei Zhang et al. · 2016 · OncoImmunology
Therapy resistance mediated by exosomes
Teresa Bernadette Steinbichler, József Dudás, Sergej Skvortsov, Ute Ganswindt, Herbert Riechelmann, Ira Skvortsova · 2019 · Molecular Cancer
Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy
Rana Shafabakhsh, Mohammad Hossein Pourhanifeh, Hamid Reza Mirzaei, Amirhossein Sahebkar, Zatollah Asemi, Hamed Mirzaei · 2019 · Pharmacological Research
Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system
Yinghong Zhai, Xiaofei Ye, Fangyuan Hu, Jinfang Xu, Xiaojing Guo, Yonglong Zhuang, Jia He · 2019 · Journal for ImmunoTherapy of Cancer
Histopathologic Features of Colitis Due to Immunotherapy With Anti-PD-1 Antibodies
Chen, Jonathan H., Pezhouh, Maryam K., Lauwers, Gregory Y., Masia, Ricard · 2017 · American Journal of Surgical Pathology
New immunotherapies targeting the PD-1 pathway
Jordan M. Chinai, Murali Janakiram, Fuxiang Chen, Wantao Chen, Mark Kaplan, Xingxing Zang · 2015 · Trends in Pharmacological Sciences